Celgene

REBLOZYL

View Prices
  1. Home
    2.  / 
  2. J Code
    3.  / REBLOZYL – J0896

Manufacturer:

Celgene

Name:

REBLOZYL

HCPCS Code Descriptor:

Injection, luspatercept-aamt, 0.25 mg

Category:

J Code

HCPCS:

J0896

NDC(s):

59572-0711-01, 59572-0775-01

Primary Type:

Anti-Anemia

Generic/Specialty Status:

Single-Source

Route of Administration:

Subcutaneous

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About:

REBLOZYL is an Anti-Anemia drug manufactured by Celgene and administered via the Subcutaneous route of administration. The J Code: J0896 is aligned to the drug REBLOZYL.

View Prices

Access Pricing and More By Registering

Register Now

HCPCS Added Date:

7/1/20

HCPCS Effective Date:

7/1/20

HCPCS Short Description:

Inj luspatercept-aamt 0.25mg

Billing and Coding Guide:

https://www.bmsaccesssupport.bmscustomerconnect.com/servlet/servlet.FileDownload?file=00P4z00001S42ZrEAJ

Patient Assistance:

https://www.bmsaccesssupport.bmscustomerconnect.com/patient

REBLOZYL - J0896